Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-08-06

Clinical Trial Update: The Efficacy and Safety Study of High Dose Donepezil in Parkinson's Disease With Dementia [Phase 2]

View source ↗

Summary

This document reports an ongoing Phase 2 trial testing high-dose donepezil for efficacy and safety in Parkinson's disease with dementia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Donepezil (donepezil)

Snippet

Sponsor: Inje University | Conditions: Parkinson's Disease | Phase 2 | Status: UNKNOWN